|ASMB -- USA Stock|| |
USD 43.55 2.00 4.81%
Non-Executive Chairman of the Board
Mr. William Ringo is Independent NonExecutive Chairman of the Board of Company, Since July 2010, Mr. Ringo was a senior advisor with Barclays Capital, the global investment banking division of Barclays Bank PLC. Since July 2010, Mr. Ringo has also served as a strategic advisor with Sofinnova Ventures, a life sciencesfocused investment firm. Prior to his advisory roles with Barclays Capital and Sofinnova Ventures, Mr. Ringo served as senior Vice President of Strategy and Business Development for Pfizer Inc., a biopharmaceutical company, from April 2008 until his retirement in April 2010. From 2004 to 2006, Mr. Ringo served as President and Chief Executive Officer of Abgenix, Inc., a private biotechnology company acquired by Amgen. Mr. Ringo served on the Onyx Pharmaceuticals, Inc. board of directors from Feburary 2011 until the October 2013 acquisition by Amgen
Age: 69 Chairman Since 2015 MBA
Ringo received his B.S. in business administration and his M.B.A. from the University of Dayton.